These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 23426829
41. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Völkl TM, Öhl L, Rauh M, Schöfl C, Dörr HG. Horm Res Paediatr; 2011; 76(6):400-10. PubMed ID: 22123283 [Abstract] [Full Text] [Related]
42. [Growth and adult height in patients with congenital adrenal hyperplasia]. Kolousková S, Zemková D, Snajderová M, Lebl J. Cas Lek Cesk; 1995 Nov 01; 134(21):689-91. PubMed ID: 8556761 [Abstract] [Full Text] [Related]
43. Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-Fékété C, Morel Y, Brauner R. J Clin Endocrinol Metab; 2003 Jun 01; 88(6):2624-33. PubMed ID: 12788866 [Abstract] [Full Text] [Related]
44. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue. Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K. Clin Endocrinol (Oxf); 2019 Jul 01; 91(1):124-130. PubMed ID: 31070802 [Abstract] [Full Text] [Related]
45. Gender change from female to male in classical congenital adrenal hyperplasia. Meyer-Bahlburg HF, Gruen RS, New MI, Bell JJ, Morishima A, Shimshi M, Bueno Y, Vargas I, Baker SW. Horm Behav; 1996 Dec 01; 30(4):319-32. PubMed ID: 9047260 [Abstract] [Full Text] [Related]
46. Factors determining final height in congenital adrenal hyperplasia. New MI, International Workshop on Management of Puberty for Optimum Auxological Results. J Pediatr Endocrinol Metab; 2001 Jul 01; 14 Suppl 2():933-7. PubMed ID: 11529398 [Abstract] [Full Text] [Related]
49. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG. Acta Paediatr; 2009 May 01; 98(5):885-91. PubMed ID: 19236311 [Abstract] [Full Text] [Related]
50. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia]. Theintz GE, Sizonenko PC. Arch Fr Pediatr; 1985 Mar 01; 42(3):211-7. PubMed ID: 4004483 [Abstract] [Full Text] [Related]
51. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Gussinyé M, Carrascosa A, Potau N, Enrubia M, Vicens-Calvet E, Ibáñez L, Yeste D. Pediatrics; 1997 Oct 01; 100(4):671-4. PubMed ID: 9310523 [Abstract] [Full Text] [Related]
52. Androgens concentrations and second-to fourth-digit ratio (2D:4D) in girls with congenital adrenal hyperplasia (21-hydroxylase deficiency). Oswiecimska JM, Ksiazek A, Sygulla K, Pys-Spychala M, Roczniak GR, Roczniak W, Stojewska M, Ziora K. Neuro Endocrinol Lett; 2012 Oct 01; 33(8):787-91. PubMed ID: 23391972 [Abstract] [Full Text] [Related]
53. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry. Bacila I, Freeman N, Daniel E, Sandrk M, Bryce J, Ali SR, Yavas Abali Z, Atapattu N, Bachega TA, Balsamo A, Birkebæk N, Blankenstein O, Bonfig W, Cools M, Costa EC, Darendeliler F, Einaudi S, Elsedfy HH, Finken M, Gevers E, Claahsen-van der Grinten HL, Guran T, Güven A, Hannema SE, Higham CE, Iotova V, van der Kamp HJ, Korbonits M, Krone RE, Lichiardopol C, Luczay A, Mendonca BB, Milenkovic T, Miranda MC, Mohnike K, Neumann U, Ortolano R, Poyrazoglu S, Thankamony A, Tomlinson JW, Vieites A, de Vries L, Ahmed SF, Ross RJ, Krone NP. Eur J Endocrinol; 2021 Apr 01; 184(4):553-563. PubMed ID: 33460392 [Abstract] [Full Text] [Related]
54. Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. Stikkelbroeck NM, Hermus AR, Suliman HM, Jager GJ, Otten BJ. J Pediatr Endocrinol Metab; 2004 Apr 01; 17(4):645-53. PubMed ID: 15198296 [Abstract] [Full Text] [Related]
55. Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia. Yau M, Rao N, Nimkarn S, Vogiatzi M. J Pediatr Endocrinol Metab; 2014 May 01; 27(5-6):549-54. PubMed ID: 24468605 [Abstract] [Full Text] [Related]
56. Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia. Verma S, Green-Golan L, VanRyzin C, Drinkard B, Mehta SP, Weise M, Eisenhofer G, Merke DP. Horm Metab Res; 2010 Jul 01; 42(8):607-12. PubMed ID: 20446239 [Abstract] [Full Text] [Related]
57. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone. Bonfig W, Schmidt H, Schwarz HP. Horm Res Paediatr; 2011 Jul 01; 75(1):32-7. PubMed ID: 20714115 [Abstract] [Full Text] [Related]
58. Anthropometric and Pubertal Outcomes in Girls With Classical Congenital Adrenal Hyperplasia. Kaur J, Singla M, Bhansali A, Bhadada S, Walia R. Indian Pediatr; 2022 Jul 15; 59(7):535-538. PubMed ID: 35596648 [Abstract] [Full Text] [Related]
59. Continuous subcutaneous hydrocortisone infusion (CSHI) in a young adolescent with congenital adrenal hyperplasia (CAH). Tuli G, Rabbone I, Einaudi S, di Gianni V, Tessaris D, Gioia E, Lala R, Cerutti F. J Pediatr Endocrinol Metab; 2011 Jul 15; 24(7-8):561-3. PubMed ID: 21932600 [Abstract] [Full Text] [Related]
60. Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period. Shetty VB, Bower C, Jones TW, Lewis BD, Davis EA. J Paediatr Child Health; 2012 Nov 15; 48(11):1029-32. PubMed ID: 23039988 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]